Ursprung des Netzwerks ersten Grades von Roel Sterken
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Biogazelle NV
 Biogazelle NV BiotechnologyHealth Technology Biogazelle NV is a research and development stage biotechnology firm. It specializes in ribonucleic acid for next generation diagnostics in the field of oncology and other diseases. The company was founded by Jan Hellemans and Jo Vandesompele in 2007 and is headquartered in Zwijnaarde, Belgium.
6
| Subsidiary | Biotechnology | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Roel Sterken
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
UGent TechTransfer
 UGent TechTransfer Investment ManagersFinance UGent TechTransfer is a venture capital firm, a subsidiary of Ghent University founded in 1999. UGent TechTransfer is headquartered in Zwijnaarde, Belgium. | Investment Managers | President | |
| Ghent University | College/University | Doctorate Degree | |
QBIC Venture Partners BV
 QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium. | Investment Managers | Founder | |
Trinean NV
 Trinean NV Electronic Equipment/InstrumentsElectronic Technology Trinean NV develops and produces nanoliter spectrophotometers and consumables. Its products include DropSense96, Xpose, and spectral content profiling. The firm covers both microfluidic structures and multi-channel spectrometry for microliter sample handling. The company was founded by Ronny Baeckstaele and Kris Naessens in 2006 and is headquartered in Gentbrugge, Belgium. | Electronic Equipment/Instruments | Director/Board Member | |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
THERAtRAME SA
 THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Biotechnology | Chairman | |
Q-Biologicals NV
 Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Chief Executive Officer |
Statistik
International
| Belgien | 9 |
Sektoral
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 9 |
| Founder | 3 |
| Independent Dir/Board Member | 3 |
| Private Equity Investor | 2 |
| Chief Executive Officer | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Roel Sterken
- Unternehmensverbindungen
